The DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.
The Crisis in Antibiotic Resistance
Abstract
The synthesis of large numbers of antibiotics over the past three decades has caused complacency about the threat of bacterial resistance. Bacteria have become resistant to antimicrobial agents as a result of chromosomal changes or the exchange of the exchange of genetic material via plasmids and transposons. Streptococcus pneumoniae, Streptococcus pyogenes, and staphylococci, organisms that cause respiratory and cutaneous infections, and members of the Enterobacteriaceae and Pseudomonas families, organisms that cause diarrhea, urinary infection, and sepsis, are now resistant to virtually all of the older antibiotics. The extensive use of antibiotics in the community and hospitals has fueled this crisis. Mechanisms such as antibiotic control programs, better hygiene, and synthesis of agents with improved antimicrobial activity need to be adopted in order to limit bacterial resistance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Overuse and antibiotic resistance have proliferated[422]”
From Enterosalivary nitrate metabolism and the microbiome: Intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health (2017) · cites this paper as [422]
Citations
Cites
The life and times of the Enterococcus
Murray, B. E. (1990) · Clinical Microbiology Reviews · doi:10.1128/cmr.3.1.46 · Cited by 1,887
Plasmid-Mediated Resistance to Vancomycin and Teicoplanin in Enterococcus Faecium
Leclercq, R., Derlot, E., Duval, J., & Courvalin, P. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807213190307 · Cited by 1,411
Enterobacter Bacteremia: Clinical Features and Emergence of Antibiotic Resistance during Therapy
Chow, J. W., Fine, M. J., Shlaes, D. M., Quinn, J. P., Hooper, D. C., Johnson, M. P., Ramphal, R., Wagener, M. M., Miyashiro, D. K., & Yu, V. L. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-8-585 · Cited by 887
Pneumococcal resistance to antibiotics
Klugman, K. P. (1990) · Clinical Microbiology Reviews · doi:10.1128/cmr.3.2.171 · Cited by 804
Extended-spectrum beta-lactamases
Philippon, A., Labia, R., & Jacoby, G. A. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.8.1131 · Cited by 776
More extended-spectrum beta-lactamases
Jacoby, G. A., & Medeiros, A. A. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.9.1697 · Cited by 704
Bugg, T. D. H., Wright, G. D., Dutka‐Malen, S., Arthur, M., Courvalin, P. M., & Walsh, C. T. (1991) · Biochemistry · doi:10.1021/bi00107a007 · Cited by 642
Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification
Leclercq, R., & Courvalin, P. M. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.7.1267 · Cited by 629
McMurry, L. M., Petrucci, R., & Levy, S. B. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.7.3974 · Cited by 606
Antimicrobial resistance of Staphylococcus aureus: genetic basis
Lyon, B. R., & Skurray, R. A. (1987) · Microbiological Reviews · doi:10.1128/mr.51.1.88-134.1987 · Cited by 593
Research works printed but not linked: 30
- AMERICAN JOURNAL OF MEDICINE 91 3B (1991).
- APPELBAUM, P. C., EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES 6: 367 (1987).
- BANERJEE, S.N., SECULAR TRENDS IN NOSOCOMIAL PRIMARY BLOOD-STREAM INFECTIONS IN THE UNITED-STATES, 1980-1989, AMERICAN JOURNAL OF MEDICINE 91: S86 (1991).
- BOYCE, J. M., JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 249: 2803 (1983). · DOI
- Bryan, L. E., Antimicrobial Drug Resistance 241 (1984).
- BUOHO, A. Y., JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 22 B: 41 (1988).
- BUSH, K, ANTIMICROB AGENTS CH 33: 339 (1989).
- COOKSON, B. D., JOURNAL OF APPLIED BACTERIOLOGY 69: 55S (1990).
- DEGUCHI, K, JAPANESE JOURNAL OF ANTIBIOTICS 42: 2133 (1990).
- Fisher, M., New Antibacterial Strategies 177 (1990).
- Higgins, C. F., New Antibacterial Strategies 193 (1990).
- KHARDORI, N, REVIEWS OF INFECTIOUS DISEASES 12: 996 (1990).
- LUJAN, R, REVISTA ESPANOLA DE QUIMIOTERAPIA 3: 323 (1990).
- McMurry, L., Proceedings of the National Academy of Sciences of the United States of America 77: 3974 (1980).
- MILATOVIC, D, EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES 6: 234 (1987).
- Mitsuhashi, S., The Aminoglycosides 97 (1982).
- MOELLERING, R, JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 28: 1 (1991).
- MUDDER, R.R., ARCH INTERN MED 147: 1672 (1987). · DOI
- NEU, H. C., AMERICAN JOURNAL OF MEDICINE 76: 11 (1984).
- NEU, H.C., AMERICAN JOURNAL OF MEDICINE 7 5A: 2 (1985).
- Neu, H. C., Human Pharmacology 613 (1991).
- Normark, S., New Antibacterial Strategies 161 (1990).
- PHILLIPS, I, JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 27: 40 (1991).
- SCHABERG, D. R., AMERICAN JOURNAL OF MEDICINE 91 3B: 725 (1991).
- SKURRAY, R. A., JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 21 C: 19 (1988).
- SLOCOMBE, B,JOURNAL OF HOSPITAL INFECTION 19: 19 (1991).
- SMITH, A, INFECTIOUS DISEASE CLINICS OF NORTH AMERICA 5: 177 (1992).
- TALLY, F. P., JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 22 A: 63 (1989).
- TENOVER, F. C., AMERICAN JOURNAL OF MEDICINE 91: S76 (1991).
- UTTLEY, AHC, VANCOMYCIN-RESISTANT ENTEROCOCCI, LANCET 1: 57 (1988).
Cited by
Sorted by citations
Items 501–600 of 1,000
Preisner, O., Lopes, J. A., Guiomar, R., Machado, J., & de Menezes, J. C. (2006) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-006-0851-1 · Cited by 89
Elimination of Macrolides, Tiamulin, and Salinomycin During Manure Storage
Schlüsener, M. P., von Arb, M. A., & Bester, K. (2006) · Archives of Environmental Contamination and Toxicology · doi:10.1007/s00244-004-0240-8 · Cited by 89
Biosynthesis of Butirosin: Transfer and Deprotection of the Unique Amino Acid Side Chain
Llewellyn, N. M., Li, Y., & Spencer, J. B. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.02.005 · Cited by 89
Burden of Methicillin‐Resistant Staphylococcus aureus: Focus on Clinical and Economic Outcomes
Lodise, T. P., & McKinnon, P. S. (2007) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.7.1001 · Cited by 88
Antibiotic combination efficacy (ACE) networks for a Pseudomonas aeruginosa model
Barbosa, C., Beardmore, R., Schulenburg, H., & Jansen, G. (2018) · PLoS Biology · doi:10.1371/journal.pbio.2004356 · Cited by 85
X-Ray Crystal Structure of Staphylococcus aureus FemA
Benson, T. E., Prince, D. B., Mutchler, V. T., Curry, K. A., Ho, A. M., Sarver, R. W., Hagadorn, J. C., Choi, G. H., & Garlick, R. L. (2002) · Structure · doi:10.1016/s0969-2126(02)00807-9 · Cited by 89
Rapid estimation of bacterial antibiotic susceptibility with flow cytometry
MASON, D. J., ALLMAN, R., Stark, J. M., & Lloyd, D. (1994) · Journal of Microscopy · doi:10.1111/j.1365-2818.1994.tb03494.x · Cited by 89
“Antibiotic-resistant strains of bacteria such as those of Staphylococcus aureus, Haemophilus influenzae, Streptococcus pneumoniae, Neisseria gonorrhoeae, Neisseria meningitidis and Gram-negative enteric bacteria are continually a problem (Spencer et d., 1990; Cohen, 1992; Neu, 1992; Kunin, 1993).”
BackgroundNettleman, M. D., Chen, Y.-C., Chang, S.-C., Sun, C.-C., Yang, L.-S., Hsieh, W.-C., & Luh, K.-T. (1997) · Infection Control & Hospital Epidemiology · doi:10.1086/647628 · Cited by 88
Current Landscape and Future Perspective of Oxazolidinone Scaffolds Containing Antibacterial Drugs
Zhao, Q., Xin, L., Liu, Y., Liang, C., Li, J., Jian, Y., Li, H., Shi, Z., Liu, H., & Cao, W. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00480 · Cited by 88
Effect of α,α-Dialkyl Amino Acids on the Protease Resistance of Peptides
Yamaguchi, H., Kodama, H., Osada, S., Kato, F., Jelokhani‐Niaraki, M., & Kondo, M. (2003) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.67.2269 · Cited by 88
Non-Classical Polycyclic β-Lactams
Gómez‐Gallego, M., Mancheño, M. J., & Sierra, M. Á. (2000) · Tetrahedron · doi:10.1016/s0040-4020(00)00378-1 · Cited by 88
Butelase‐Mediated Macrocyclization of d ‐Amino‐Acid‐Containing Peptides
Nguyen, G. K. T., Hemu, X., Quek, J. P., & Tam, J. P. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201607188 · Cited by 87
Microbial Food Safety in Animal Agriculture: Current Topics
Torrence, M. E., & Isaacson, R. E. (2003) · Cited by 86
Biodegradation of Pharmaceutical Wastes in Treated Sewage Effluents by Bacillus subtilis 1556WTNC
Al-Gheethi, A. A. S., & Ismail, N. (2014) · Environmental Processes · doi:10.1007/s40710-014-0034-6 · Cited by 86
“Many bacteria have been reported to produce βlactamases to reduce the pharmacological potency of the β-lactam antibiotics (Neu 1992).”
BackgroundResistance to antibiotics used in dermatological practice
Espersen (1998) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1998.1390s3004.x · Cited by 87
Nayak, A. R., Tinge, S. A., Tart, R. C., McDaniel, L. S., Briles, D. E., & Curtiss, R. (1998) · Infection and Immunity · doi:10.1128/iai.66.8.3744-3751.1998 · Cited by 87
“The emergence of penicillin resistance and multi-drug-resistant strains threatens the clinical management of pneumococcal disease (28, 36).”
BackgroundEnergetic, structural, and antimicrobial analyses of β-lactam side chain recognition by β-lactamases
Caselli, E., Powers, R. A., Blasczcak, L. C., Wu, C. Y. E., Prati, F., & Shoichet, B. K. (2001) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00052-1 · Cited by 87
“L-Lactamases catalyze the hydrolysis of L-lactam antibiotics, such as penicillins and cephalosporins, and are the most widespread bacterial resistance mechanism to these drugs [1].”
BackgroundDiagnosing Antibiotic Resistance Using Nucleic Acid Enzymes and Gold Nanoparticles
Mohamed, M. A. A., Kozlowski, H. N., Kim, J., Zagorovsky, K., Kántor, M., Feld, J. J., Mubareka, S., Mazzulli, T., & Chan, W. C. W. (2021) · ACS Nano · doi:10.1021/acsnano.0c09902 · Cited by 86
Structure–activity relations of parasin I, a histone H2A-derived antimicrobial peptide
Koo, Y. S., Kim, J. M., Park, I. Y., Yu, B. J., Jang, S. A., Kim, K., Park, C. B., Cho, J. H., & Kim, S. C. (2008) · Peptides · doi:10.1016/j.peptides.2008.02.019 · Cited by 86
“019 development of new classes of antimicrobial agents [24].”
The fate of new bacterial genes
Kuo, C., & Ochman, H. (2008) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2008.00140.x · Cited by 89
Arshad, N., Zitterl‐Eglseer, K., Hasnain, S., & Heß, M. (2008) · Phytotherapy Research · doi:10.1002/ptr.2528 · Cited by 87
“NCCLS: Wayne, PA. Neu HC. 1992.”
Satasia, S. P., Kalaria, P. N., & Raval, D. K. (2014) · Organic & Biomolecular Chemistry · doi:10.1039/c3ob42132e · Cited by 86
Irrational antibiotic prescribing: a local issue or global concern?
Hashemi, S., Nasrollah, A., & Rajabi, M. (2013) · EXCLI journal · doi:10.17877/de290r-10752 · Cited by 86
An economic perspective on policy to reduce antimicrobial resistance
Coast, J., Smith, R., & Millar, M. R. (1998) · Social Science & Medicine · doi:10.1016/s0277-9536(97)00132-9 · Cited by 86
Biosensors for Monitoring Airborne Pathogens
Fronczek, C. F., & Yoon, J. (2015) · SLAS TECHNOLOGY · doi:10.1177/2211068215580935 · Cited by 85
“Further compounding costs and complications is the developing prevalence of antibiotic-resistant strains.(124,125) To reduce morbidity, mortality, and cost, it would be highly beneficial to detect low levels of Strep bacteria in hospitals and clinics to reduce the risk of transmission to immunocompromised patients.”
BackgroundMulti-directional electrodeposited gold nanospikes for antibacterial surface applications
Elbourne, A. J., Coyle, V. E., Truong, V. K., Sabri, Y. M., Kandjani, A. E., Bhargava, S. K., Ivanova, E. P., & Crawford, R. J. (2018) · Nanoscale Advances · doi:10.1039/c8na00124c · Cited by 85
Non-antibiotic pharmaceuticals promote conjugative plasmid transfer at a community-wide level
Wang, Y., Yu, Z., Ding, P., Lu, J., Klümper, U., Murray, A. K., Gaze, W. H., & Guo, J. (2022) · Microbiome · doi:10.1186/s40168-022-01314-y · Cited by 83
Sharma, M., Eriksson, B., Marrone, G., Dhaneria, S., & Lundborg, C. S. (2012) · BMC Infectious Diseases · doi:10.1186/1471-2334-12-155 · Cited by 85
“Rising rates of bacterial resistance is increasingly seen as a global problem [7-10].”
BackgroundAlghaithy, A. A., Bilal, N. E., Gedebou, M., & Weily, A. H. (2000) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(00)90066-x · Cited by 85
Preparation of gold nanoparticles by novel bacterial exopolysaccharide for antibiotic delivery
Pradeepa, Vidya, S. M., Mutalik, S., Bhat, K. U., Huilgol, P., & Avadhani, K. S. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.04.022 · Cited by 85
Antimicrobial Properties of Copper-Doped ZnO Coatings under Darkness and White Light Illumination
Hassan, I. A., Sathasivam, S., Nair, S. P., & Carmalt, C. J. (2017) · ACS Omega · doi:10.1021/acsomega.7b00759 · Cited by 84
Pharmaceutical Applications of Iron-Oxide Magnetic Nanoparticles
Bruschi, M. L., & de Toledo, L. D. A. S. (2019) · Magnetochemistry · doi:10.3390/magnetochemistry5030050 · Cited by 83
Dharavath, R., Nagaraju, N., Reddy, M. R., Ashok, D., Sarasija, M., Manga, V., Vani, T., Jyothi, K., & Prashanthi, G. (2020) · RSC Advances · doi:10.1039/d0ra01052a · Cited by 84
Cuevas, C., Batura, N., Wulandari, L. P. L., Khan, M. S., & Wiseman, V. L. (2021) · Health Policy and Planning · doi:10.1093/heapol/czab021 · Cited by 84
Factors Affecting Latino Adults' Use of Antibiotics for Self-Medication
Mainous, A. G., Díaz, V. A., & Carnemolla, M. A. (2008) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2008.02.070149 · Cited by 84
“Unfortunately, excessive use of antibiotics has contributed to the spread of the important clinical and public health problem of antibiotics resistance.(1,2) In some countries, the use of antimicrobials without a prescription is encouraged by the lack of laws restricting antibiotic sales or a failure to enforce those…”
BackgroundPhenotypic Antimicrobial Susceptibility Testing with Deep Learning Video Microscopy
Yu, H. M., Jing, W., Iriya, R., Yang, Y., Syal, K., Mo, M., Grys, T. E., Haydel, S. E., Wang, S., & Tao, N. J. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b01128 · Cited by 87
Models and mechanisms for bacteriocin action and application
Montville, T. J., Winkowski, K., & Ludescher, R. D. (1995) · International Dairy Journal · doi:10.1016/0958-6946(95)00034-8 · Cited by 84
Bera, S., Zhanel, G. G., & Schweizer, F. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm1000437 · Cited by 83
Mouz, N., Gordon, E. J., Guilmi, A. M. D., Petit, I., Pétillot, Y., Dupont, Y., Hakenbeck, R., Vernet, T., & Dideberg, O. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13403 · Cited by 83
Development of immunization trials against Pasteurella multocida
Ahmad, T. A., Rammah, S. S., Sheweita, S. A., Haroun, M., & Sayed, L. H. E. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.11.068 · Cited by 82
“[29] Neu HC.”
BackgroundThe complexed structure and antimicrobial activity of a non‐β‐lactam inhibitor of AmpC β‐lactamase
Powers, R. A., Blázquez, J., Weston, G. S., Shoichet, B. K., Morosini, M.-I., & Baquero, F. (1999) · Protein Science · doi:10.1110/ps.8.11.2330 · Cited by 82
Evidence for myosin motors on organelles in squid axoplasm.
Bearer, E. L., DeGiorgis, J. A., Bodner, R. A., Kao, A. W., & Reese, T. S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11252 · Cited by 82
Yan, C., Wang, F., Liu, H., Liu, H., Pu, S., Lin, F., Geng, H., Ma, S., Zhang, Y., ZhiJun, T., et al. (2020) · Environmental Research · doi:10.1016/j.envres.2020.109869 · Cited by 86
Burk, D. L., Ghuman, N., Wybenga-Groot, L. E., & Berghuis, A. M. (2003) · Protein Science · doi:10.1110/ps.0233503 · Cited by 80
“Copyright © 2003 The Protein Society426 the extensive use of antibiotics, notably in agriculture (Witte 1998, 2000), the evolutionary pressure has been sufficiently large that the concomitant rise in antibiotic resistance has been dramatic (Neu 1992).”
Backgroundβ‐lactamase producing bacteria in adult periodontitis
Winkelhoff, A. J. V., Winkel, E. G., Barendregt, D., Dellemijn‐Kippuw, N., Nes, A. S.-V., & van der Velden, U. (1997) · Journal Of Clinical Periodontology · doi:10.1111/j.1600-051x.1997.tb00226.x · Cited by 81
Aretz, W., Meiwes, J., SEIBERT, G., Vobis, G., & Wink, J. M. (2000) · The Journal of Antibiotics · doi:10.7164/antibiotics.53.807 · Cited by 81
Evolving Risk Factors for Infectious Complications of Cancer Therapy
Chanock, S. J. (1993) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(18)30221-1 · Cited by 80
Solar Photo-Fenton as Finishing Step for Biological Treatment of a Pharmaceutical Wastewater
Sirtori, C., Zapata, A., Oller, I., Gernjak, W., Agüera, A., & Malato, S. (2009) · Environmental Science & Technology · doi:10.1021/es802550y · Cited by 80
Gounarides, J., Chen, A., & Shapiro, M. J. (1999) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(98)00512-x · Cited by 80
Azad, M., Rahman, M. M., Amin, R., Begum, M. I. A., Fries, R., Husna, A., Khairalla, A. S., Badruzzaman, A. T. M., Zowalaty, M. E. E., Lampang, K. N., et al. (2019) · Pathogens · doi:10.3390/pathogens8030118 · Cited by 82
“Improper antimicrobial treatment is the main culprit that promotes the emergence, selection, and spread of antimicrobial resistant bacterial strains among animals and humans [8,9].”
BackgroundKumar, G. V. S., Prasad, Y. R., Mallikarjuna, B. P., & Chandrashekar, S. M. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.08.023 · Cited by 79
Salehi, T. Z., & Bonab, S. F. (2006) · International Journal of Poultry Science · doi:10.3923/ijps.2006.677.684 · Cited by 79
“Garau et al. both veterinary and human medicine (Neu, 1992; Witte, (1999) suggested that the high prevalence of 1998).”
BackgroundReceptor-based screening assays for the detection of antibiotics residues – A review
Ahmed, S., Ning, J., Cheng, G., Ahmad, I., Li, J., Mingyue, L., Qu, W., Iqbal, M., Shabbir, M. A. B., & Yuan, Z. (2017) · Talanta · doi:10.1016/j.talanta.2017.01.057 · Cited by 79
Altincicek, B., Hintz, M., Sanderbrand, S., Wiesner, J., Beck, E., & Jomaa, H. (2000) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2000.tb09307.x · Cited by 79
“Because antibiotics are often ine¡ective against this pathogen, infections are di¤cult to treat [1].”
BackgroundRak, M. J., Friščić, T., & Moores, A. (2016) · RSC Advances · doi:10.1039/c6ra03711a · Cited by 78
Wang, H., Song, Z., Li, S., Wu, Y., & Han, H. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b09824 · Cited by 78
pH Dependence of Microbe Sterilization by Cationic Antimicrobial Peptides
Walkenhorst, W. F., Klein, J. W., Vo, P. N. L., & Wimley, W. C. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00063-13 · Cited by 78
Bag, A., Bhattacharyya, S. K., Pal, N. K., & Chattopadhyay, R. R. (2012) · Microbiological Research · doi:10.1016/j.micres.2012.02.005 · Cited by 78
Synergistic Antimicrobial Activity of Metabolites Produced by a Nonobligate Bacterial Predator
Cain, C. C., Lee, D., Waldo, R. H., Henry, A. T., Casida, E. J., Wani, M. C., Wall, M. E., Oberlies, N. H., & Falkinham, J. O. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.7.2113-2117.2003 · Cited by 78
“Driven by the appearance of antibiotic-resistant bacterial pathogens, including Mycobacterium tuberculosis, Staphylococcus aureus, Neisseria gonorrohoeae, Haemophilus influenzae, and Pseudomonas aeruginosa (14, 17, 29), there is an everpressing need for new antibiotics.”
BackgroundPallarés, R., Dick, R., Wenzel, R. P., Adams, J. R., & Nettleman, M. D. (1993) · Infection Control and Hospital Epidemiology · doi:10.1086/646765 · Cited by 78
Impacts of development and global change on the epidemiological environment
Daily, G. C., & Ehrlich, P. R. (1996) · Environment and Development Economics · doi:10.1017/s1355770x00000656 · Cited by 78
“Neu, H.C. (1992), "The crisis in antibiotic resistance', Science 257:1066-1077.”
BackgroundInfluentialCass, R. T., Villa, J. S., Karr, D. E., & Schmidt, D. E. (2001) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.246 · Cited by 77
Agustiandari, H., Lubelski, J., van Saparoea, H. B. V. D. B., Kuipers, O. P., & Driessen, A. J. M. (2007) · Journal of Bacteriology · doi:10.1128/jb.01151-07 · Cited by 77
van Oort, P. M. P., Póvoa, P. M. S. R., Schnabel, R. M., Dark, P. M., Artigas, A., Bergmans, D. C. J. J., Felton, T., Coelho, L., Schultz, M. J., Fowler, S. J., et al. (2018) · Journal of Breath Research · doi:10.1088/1752-7163/aaa499 · Cited by 77
Song, Y., Lü, F., Li, H., Wang, H., Zhang, M., Liu, Y., & Kang, Z. (2018) · ACS Applied Bio Materials · doi:10.1021/acsabm.8b00421 · Cited by 77
Chakraborty, S. P., Mahapatra, S. K., Bal, M., & Roy, S. (2011) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 74
Catalytic Mechanism of Class B2 Metallo-β-lactamase
Xu, D., Xie, D., & Guo, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512517200 · Cited by 76
Schmitz, K. R., & Sauer, R. T. (2014) · Molecular Microbiology · doi:10.1111/mmi.12694 · Cited by 76
“Introduction The emergence of bacterial pathogens resistant to conventional antibiotics has led to an urgent need for novel therapeutics (Neu, 1992, Levy & Marshall, 2004, Howard et al., 2013).”
BackgroundAlcaide, B., Almendros, P., & Alonso, J. M. (2011) · Molecules · doi:10.3390/molecules16097815 · Cited by 76
“faecalis, two drug-resistant common pathogens which have generated major concern [12-14].”
BackgroundEvolution of multi-resistance plasmids in Australian clinical isolates of Escherichia coli
Sherley, M., Gordon, D. M., & Collignon, P. (2004) · Microbiology · doi:10.1099/mic.0.26773-0 · Cited by 76
“coli (Bell & Turnidge, 1995), and is frequently plasmid-mediated (Neu, 1992).”
BackgroundAbinaya, C., Marikkannan, M., Manikandan, M., Mayandi, J., Suresh, P., Shanmugaiah, V., Ekstrum, C., & Pearce, J. M. (2016) · Materials Chemistry and Physics · doi:10.1016/j.matchemphys.2016.09.039 · Cited by 76
Lessard, I. A. D., Pratt, S. D., McCafferty, D. G., Bussiere, D. E., Hutchins, C. W., Wanner, B. L., Katz, L., & Walsh, C. T. (1998) · Chemistry & Biology · doi:10.1016/s1074-5521(98)90005-9 · Cited by 77
Chirgadze, N. Y., Briggs, S. L., McAllister, K. A., Fischl, A. S., & Zhao, G. (2000) · The EMBO Journal · doi:10.1093/emboj/19.20.5281 · Cited by 75
Antibiotic Resistance Genes in Coagulase-negative Staphylococci Isolated from Food
Perreten, V., Giampà, N., Schuler-Schmid, U., & Teuber, M. (1998) · Systematic and Applied Microbiology · doi:10.1016/s0723-2020(98)80014-3 · Cited by 75
MYSTIC (Meropenem Yearly Susceptibility Test Information Collection): a global overview
Turner, P. J. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.suppl_2.9 · Cited by 75
Hao, Z., Lin, X., Li, J., Yin, Y., Gao, X., Wang, S., & Liu, Y. (2020) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2020.112789 · Cited by 74
Jadhav, G. R., Shaikh, M. U., Kale, R. P., Shiradkar, M. R., & Gill, C. H. (2008) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2008.12.001 · Cited by 74
Ultraviolet A/Riboflavin Collagen Cross-Linking for Treatment of Moderate Bacterial Corneal Ulcers
Bamdad, S., Malekhosseini, H., & Khosravi, A. (2015) · Cornea · doi:10.1097/ico.0000000000000375 · Cited by 74
“The increasing resistance to antibiotics can lead to destructive outcomes.(9) Therefore, it seems necessary to focus on alternative and complementary treatment options for the management of bacterial keratitis.”
BackgroundFroom, P., Culpepper, L., Green, L. A., MELKER, R. A. D., Grob, P. R., Heeren, T., & van Balen, F. A. M. (2001) · PubMed · Cited by 71
New Treatments for Bacterial Keratitis
Wong, R. L. M., Gangwani, R. A., Yu, L. W.-H., & Lai, J. S. M. (2012) · Journal of Ophthalmology · doi:10.1155/2012/831502 · Cited by 74
“Microorganisms develop resistance due to chromosomal mutation, expression of latent chromosomal genes by induction or exchange of genetic material via transformation [9, 10].”
BackgroundHermann, J. C., Ridder, L., Höltje, H., & Mulholland, A. J. (2005) · Organic & Biomolecular Chemistry · doi:10.1039/b512969a · Cited by 74
Overview of Resistance in the 1990s
File, T. M. (1999) · CHEST Journal · doi:10.1378/chest.115.suppl_1.3s · Cited by 74
Diagnosis and Treatment of Nosocomial Pneumonia in Patients in Intensive Care Units
Chastre, J. E., Fagon, J.-Y., & Trouillet, J. L. (1995) · Clinical Infectious Diseases · doi:10.1093/clind/21.supplement_3.s226 · Cited by 74
“aeruginosa isolates are resistant to all the fluoroquinolones [17].”
BackgroundBowe, W. P., Filip, J. C., DiRienzo, J. M., Volgina, A., & Margolis, D. J. (2006) · PubMed · Cited by 73
Maguire, A. J., Brown, D. F. J., Gray, J. J., & Desselberger, U. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.1022-1029.2001 · Cited by 73
“With the increasing problem of resistance to a wide spectrum of antimicrobial agents in an increasing number of bacterial isolates (18), both in the hospital and in community settings, the dissemination of antimicrobial resistance genes between organisms and patients is of great concern.”
BackgroundMacdonald, T. J., Wu, K., Sehmi, S. K., Noimark, S., Peveler, W. J., du Toit, H., Voelcker, N. H., Allan, E., MacRobert, A. J., Gavriilidis, A., et al. (2016) · Scientific Reports · doi:10.1038/srep39272 · Cited by 73
Inappropriateness and Variability of Antibiotic Prescription among French Office-Based Physicians
Guillemot, D., Carbon, C., Vauzelle-Kervroedan, F., Balkau, B., Maison, P., Bouvenot, G., & Eschwège, É. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(97)00221-7 · Cited by 73
Blondelle, S. E., Pérez‐Payá, E., & Houghten, R. A. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.5.1067 · Cited by 73
Widespread Use of Fluoroquinolones Versus Emerging Resistance in Pneumococci
Goldstein, E. J. C., & Garabedian‐Ruffalo, S. M. (2002) · Clinical Infectious Diseases · doi:10.1086/344768 · Cited by 73
“However, the broad use of antimicrobial agents has directly contributed to the emergence and increasing prevalence of resistant strains [3-6]; currently, 35%-40% ofpneumococcal isolates are resistant to penicillin, of which -60% express high-level resistance (defined as an MIC of penicillin >22 /g/ mL) [2].”
BackgroundRana, P., Ghouse, S. M., Akunuri, R., Madhavi, Y. V., Chopra, S., & Nanduri, S. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112757 · Cited by 72
Fluorocyclines. 2. Optimization of the C-9 Side-Chain for Antibacterial Activity and Oral Efficacy
Clark, R. B., Hunt, D. K., He, M., Achorn, C., Chen, C.-L., Deng, Y., Fyfe, C., Grossman, T. H., Hogan, P. C., O’Brien, W. J., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm201467r · Cited by 72
Li, Y., Llewellyn, N. M., Giri, R., Huang, F., & Spencer, J. B. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2005.04.010 · Cited by 74
Antimicrobial peptides from the venom gland of the social wasp Vespa tropica
Yang, X., Wang, Y., Lee, W., & Zhang, Y. (2013) · Toxicon · doi:10.1016/j.toxicon.2013.08.056 · Cited by 72
Fijałkowski, K., Peitler, D., & Karakulska, J. (2016) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2016.09.001 · Cited by 72
“Also in this case, different species of staphylococci have been suggested as a reservoir of antibiotic resistance genes (Chajęcka-Wierzchowska et al., 2014; Kloos and Bannerman, 1994; Neu, 1992) which can be transferred to S. aureus, making it resistant to multiple agents (Al-Masaudi et al., 1991).”
BackgroundIndividual and group antimicrobial usage rates on 34 farrow-to-finish swine farms in Ontario, Canada
Dunlop, R. H., McEwen, S. A., Meek, A. H., Black, W. D., Clarke, R. C., & Friendship, R. M. (1998) · Preventive Veterinary Medicine · doi:10.1016/s0167-5877(97)00093-7 · Cited by 72
Johnson, S., Nolan, S., & Gulland, F. (1998) · PubMed · Cited by 71
Chueca, B., Pagán, R., & García‐Gonzalo, D. (2014) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2014.08.008 · Cited by 71
Richter, S., Anderson, V. J., Garufi, G., Lu, L., Budzik, J. M., Joachimiak, A., He, C., Schneewind, O., & Missiakas, D. M. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06533.x · Cited by 70
“At least for some diseases, drug-resistant microbes represent harbingers of a return to the preantibiotic era (Neu, 1992).”
BackgroundPlouguerné, E., Hellio, C., Deslandes, É., Véron, B., & Stiger‐Pouvreau, V. (2008) · Botanica Marina · doi:10.1515/bot.2008.026 · Cited by 71
Prasanth, C. S., Karunakaran, S. C., Paul, A. K., Kussovski, V. K., Mantareva, V. N., Ramaiah, D., Selvaraj, L., Ангелов, И., Avramov, L. A., Nandakumar, K., et al. (2013) · Photochemistry and Photobiology · doi:10.1111/php.12198 · Cited by 71
“Four samples groups with microbial cells were collected: (1) light control (LC) —without photosensitizer, but illuminated; (2) dark control (DC)—with photosensitizer, but no light (dark toxicity); (3) control (C)—only bacterial suspension (no photosensitizer, no light) and (4) aPDT treated group.”
BackgroundMethod
Metadata
- Authors
- Neu, H. C.
- Affiliations
- Columbia University (US)
- Corresponding author
- Neu, Harold C.
- Venue
- Science
- Published
- 1992-08-21
- Volume
- 257
- Issue
- 5073
- Pages
- 1064-1073
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1980595924
- Cited by
- 2,834
- References
- 109
- Citations by year
- 2026: 23 · 2025: 48 · 2024: 57 · 2023: 71 · 2022: 91 · 2021: 93 · 2020: 123 · 2019: 100 · 2018: 122 · 2017: 123 · 2016: 105 · 2015: 87 · 2014: 95 · 2013: 109 · 2012: 99
- FWCI
- 46.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Keywords
- antibiotic resistance, bacterial resistance, plasmids, transposable elements, horizontal gene transfer, Streptococcus pneumoniae, Streptococcus pyogenes, Staphylococcus, Enterobacteriaceae, Pseudomonas, antibiotic overuse, hygiene, novel antimicrobial agents
- MeSH terms
- Anti-Bacterial Agents, Bacterial Infections, Cross Infection, Drug Resistance, Microbial, Enterobacteriaceae, Haemophilus influenzae, Humans, Staphylococcus, Streptococcus pneumoniae, Streptococcus pyogenes, Enterococcus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review